StonvexLoading…
StonvexStonvexStonvexCore line items from MDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 (Est.) Expected 2026-06-03 | Q1 2026 2026-01-23 | Q4 2025 2025-10-24 | Q3 2025 2025-07-25 | Annual 2025 2025-04-25 |
|---|---|---|---|---|---|
Revenue | $9.73B | $26.56B | $17.54B | $8.58B | $33.54B |
Operating Income | Not available | $4.59B | $3.13B | $1.45B | $5.96B |
Net Income | Not available | $3.56B | $2.41B | $1.04B | $4.66B |
EPS (Diluted) | $1.56 | $2.76 | $1.87 | $0.81 | $3.61 |
Total Assets | Not available | $91.48B | $91.35B | $90.97B | $91.68B |
Total Liabilities | Not available | $42.29B | $42.49B | $42.84B | $43.42B |
Cash & Equivalents | Not available | $1.15B | $1.28B | $1.27B | $2.22B |
Free Cash Flow OCF − CapEx | Not available | $3.34B | $1.04B | $584.00M | $5.18B |
Shares Outstanding | Not available | 1.28B | 1.28B | 1.28B | 1.28B |